We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cloned Gene Content Developed for Multiple Proteomics Applications

By Biotechdaily staff writers
Posted on 15 May 2008
Promega Corp. (Madison, WI, USA) has entered into an agreement with GeneCopoeia, Inc.(Germantown, MD, USA) to combine its HaloTag protein fusion technology with GeneCopoeia's extensive library of human and mouse open reading frame (ORF) OmicsLink sequences. The resulting OmicsLink ORF expression clones with HaloTag are ready for use, offering a potentially weeks of timesavings to customers.

The large number of expression-ready ORF clones with HaloTag, combined with fluorescent or other ligands for HaloTag and optimized assay protocols, provide a complete solution broadly applicable to proteomics research, supporting both biochemical and cellular analysis of protein function.

"Our aim is to support scientists in their research, and this combined resource will enable them to easily incorporate these tools to improve protein function experiments,” explained Promega vice president of marketing Andy Bertera. "This collaboration with GeneCopoeia allows us to offer incredible breadth of prepared gene content to complement the multiple protein applications enabled by the HaloTag platform.”

"HaloTag complements our collections of genome-wide OmicsLink full length cDNA clones from human, mouse, and other species,” said Dr. Sun Lu, executive vice president of GeneCopoeia, GeneCopoeia's 20,000 human and 15,000 mouse ORF clones were generated from sequence validated full length cDNA clones or high quality tissue cDNA libraries using the company's proprietary high-fidelity cloning technologies.

HaloTag is a multi-functional protein tag that binds covalently and specifically to a variety of synthetic ligands, and which enables tagged proteins to be labeled with fluorophores for both in-vitro and in-vivo imaging, or with immobilization agents (beads or other surfaces) for purification. Covalent and specific binding of a variety of synthetic reporter and the immobilization ligands to HaloTag fusion proteins allow detection and or solid-phase fixation of tagged proteins.

Promega provides innovative solutions and technical support to the life sciences industry. The company's 2000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics, and human identification.

GeneCopoeia is a manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.


Related Links:
Promega
GeneCopoeia

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
15 May 2008  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
15 May 2008  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
15 May 2008  |   BioResearch